Dispensing Solution Incorporating Biometrics Will Ensure Safe, Secure and
Convenient Access to Patient Medications
WALL, N.J., Oct. 8 /PRNewswire/ -- BIO-key International, Inc., a leader in finger-based biometric identification and wireless public safety solutions, today announced that McKesson Provider Technologies is deploying BIO-key's WEB-key(R) biometric identification technology to enhance the security and convenience of access to medication dispensing cabinets.
McKesson will incorporate BIO-key's award-winning WEB-key technology into the AcuDose-Rx(R) system to authenticate the identity of users accessing patient medications. With the superior accuracy of the WEB-key biometric authentication software, users no longer need to rely on passwords, which can be easily forgotten or compromised. Authorized users simply touch a sensor to gain access to patient medications.
"By selecting BIO-key's finger print identification technology, the AcuDose-Rx FastEntry(TM) biometrics option provides our customers with unique, industry-leading capability," said Jeff Thompson, Product Manager for McKesson's Automation Solution Group. "The NIST-certified algorithm provides positive user identification for security and supports one-touch rapid access to the cabinet. Our customers also value the ability to enroll multiple finger prints from each user so the use of biometrics is not compromised by minor trauma to any one finger. FastEntry(TM) is one of many noteworthy enhancements in McKesson's latest Connect-Rx(R) software version, which also includes significant enhancements to expand the safety, security, and operational efficiency of AcuDose-Rx."
"In choosing our WEB-key solution, McKesson has the tools to expand its deployment to add finger print biometrics into other personnel authentication applications. For example, they can easily expand the system to replace usernames and password authentication for any current workflow process to improve security and convenience for users accessing a secure area in the hospital or accessing confidential patient records," added Jim Sullivan, BIO-key's Director of Commercial Sales.
"We are pleased to be working with McKesson, an international leader in healthcare systems and solutions. By adopting BIO-key's biometrics, McKesson will improve the security, convenience and cost of managing drug and material distribution," stated Mike DePasquale BIO-key's Chief Executive Officer. "We have high expectations that our partnership will change the dynamics for hospitals around the world."
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions and information services to law enforcement departments, public safety agencies, government and private sector customers. BIO-key's mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases. BIO-key's high performance, scalable, cost-effective and easy-to- deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise data to improve security, convenience and privacy and to reduce identity theft. Over 750 police departments in North America use BIO-key solutions, making BIO-key the leading supplier of mobile and wireless solutions for law enforcement. (http://www.bio-key.com)
McKesson Corporation, currently ranked 18th on the FORTUNE 500, is a healthcare services and healthcare information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson is the longest-operating company in healthcare today, and will mark 175 years of continuous operations in 2008. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit http://www.mckesson.com.
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. The words "estimate," "project," "intends," "expects," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Media Contact: BIO-key International, Inc.
|SOURCE BIO-key International, Inc.|
Copyright©2008 PR Newswire.
All rights reserved